Aclarion (ACON) director boosts stake with 21,122-share buy
Rhea-AI Filing Summary
Aclarion, Inc. director Ryan Bond reported an open-market purchase of Aclarion common stock. On August 13, 2026, he purchased 21,122 shares of common stock at $2.37 per share on the public market. Following this transaction, his direct holdings increased to 76,122 shares of Aclarion common stock. The filing indicates the Rule 10b5-1 trading-plan checkbox was not selected.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 21,122 shares
Net Buy
1 txn
Insider
Bond Ryan
Role
Director
Bought
21,122 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 21,122 | $2.37 | $50K |
Holdings After Transaction:
Common Stock — 76,122 shares (Direct)
Footnotes (1)
- F1. The Reporting Person purchased common stock on the public market on 08/13/2026.
Key Figures
Shares Purchased: 21,122 shares
Purchase Price: $2.37 per share
Total Holdings After Transaction: 76,122 shares
+2 more
5 metrics
Shares Purchased
21,122 shares
Common Stock bought on August 13, 2026
Purchase Price
$2.37 per share
Price for the August 13, 2026 open-market purchase
Total Holdings After Transaction
76,122 shares
Direct ownership of Aclarion common stock following the purchase
Net Buy Shares
21,122 shares
Net buy activity reported in this Form 4
Buy Transactions Count
1
Number of buy transactions reported in the filing
Key Terms
open market, Rule 10b5-1, non-derivative
3 terms
open market market
"Purchase in open market or private transaction"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
Rule 10b5-1 regulatory
"The filing indicates the Rule 10b5-1 trading-plan checkbox was not selected"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
non-derivative financial
"transaction_type":"non-derivative"
FAQ
What insider transaction did ACON director Ryan Bond report?
Ryan Bond reported a purchase of Aclarion, Inc. (ACON) common stock. On August 13, 2026, he bought shares on the public market, increasing his direct ownership position in the company.
Was Ryan Bond’s ACON stock purchase made under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox was not selected for this transaction. A footnote states the common stock was purchased on the public market on August 13, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.